Search

Your search keyword '"Sylviane Hoos"' showing total 20 results
Start Over Author "Sylviane Hoos" Topic molecular biology
20 results on '"Sylviane Hoos"'

1. The c‐di‐ <scp>AMP</scp> ‐binding protein <scp>CbpB</scp> modulates the level of <scp>ppGpp</scp> alarmone in Streptococcus agalactiae

Author

Giovanni Covaleda‐Cortés, Ariel Mechaly, Terry Brissac, Heike Baehre, Laura Devaux, Patrick England, Bertrand Raynal, Sylviane Hoos, Myriam Gominet, Arnaud Firon, Patrick Trieu‐Cuot, Pierre Alexandre Kaminski, Biologie des Bactéries pathogènes à Gram-positif - Biology of Gram-Positive Pathogens, Université Paris Cité (UPCité)-Microbiologie Intégrative et Moléculaire (UMR6047), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Cristallographie (Plateforme) - Crystallography (Platform), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Hannover Medical School [Hannover] (MHH), Biophysique Moléculaire (plateforme) - Molecular Biophysics (platform), This work was supported by grants from the French Government ‘Laboratory of Excellence - Integrative Biology of Emerging Infectious Diseases’ (LabEx IBEID, grant number ANR-10-LABX-62-IBEID to PTC), the Fondation pour la Recherche Médicale (FRM grant number DEQ20181039599 to PTC)., We acknowledge SOLEIL for provision of synchrotron radiation facilities, and we thank the staff of beamlines PROXIMA-1 and PROXIMA-2A for assistance. The authors are grateful to the Staff of the Crystallography platform at the Institut Pasteur for robot-driven crystallization screenings. We acknowledge Eduard Baquero Salazar for his help during the early stage of this work. We also acknowledge the help of Mariette Matondo and Thibault Chaze from the Proteomics facility of Institut Pasteur., and ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010)

Subjects
CbpB protein, Cyclic diadenosine monophosphate (c‐di‐AMP), [SDV]Life Sciences [q-bio], X‐ray crystallography & binding, Streptococcus, Cell Biology, Potassium homeostasis, CBS domain, Molecular Biology, Biochemistry
Abstract

International audience; Cyclic di-AMP is an essential signaling molecule in Gram-positive bacteria. This second messenger regulates the osmotic pressure of the cell by interacting directly with the regulatory domains, either RCK_C or CBS domains, of several potassium and osmolyte uptake membrane protein systems. Cyclic di-AMP also targets stand-alone CBS domain proteins such as DarB in Bacillus subtilis and CbpB in Listeria monocytogenes. We show here that the CbpB protein of Group B Streptococcus binds c-di-AMP with a very high affinity. Crystal structures of CbpB reveal the determinants of binding specificity and significant conformational changes occurring upon c-di-AMP binding. Deletion of the cbpB gene alters bacterial growth in low potassium conditions most likely due to a decrease in the amount of ppGpp caused by a loss of interaction between CbpB and Rel, the GTP/GDP pyrophosphokinase.

Published
2023

2. Structural basis for the allosteric inhibition of UMP kinase from Gram‐positive bacteria, a promising antibacterial target

Author

Patrick Walter, Ariel Mechaly, Julien Bous, Ahmed Haouz, Patrick England, Joséphine Lai‐Kee‐Him, Aurélie Ancelin, Sylviane Hoos, Bruno Baron, Stefano Trapani, Patrick Bron, Gilles Labesse, Hélène Munier‐Lehmann, Chimie et Biocatalyse, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Cristallographie (Plateforme) - Crystallography (Platform), Centre de Biologie Structurale [Montpellier] (CBS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Biophysique Moléculaire (Plate-forme), Biophysique Moléculaire (plateforme) - Molecular Biophysics (platform), This work was supported by the European Union’s Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie Skłodowska-Curie Grant Agreement No. 675555, Accelerated Early staGe drug discovery (AEGIS) project (to HML). The project was also supported in part by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Santé Et de la Recherche Médicale (INSERM), the Institut Pasteur and the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INBS-05. PW was the recipient of a PhD fellowship from the EU H2020 (2014-2020) under the Marie Skłodowska-Curie Grant Agreement No. 675555, Accelerated Early staGe drug discovery (AEGIS)., ANR-10-INBS-0005,FRISBI,Infrastructure Française pour la Biologie Structurale Intégrée(2010), and European Project: 675555,H2020,H2020-MSCA-ITN-2015,AEGIS(2016)

Subjects
crystal structure, allostery, [SDV]Life Sciences [q-bio], Cryoelectron Microscopy, Uridine Triphosphate, Cell Biology, nucleotide metabolism, Gram-Positive Bacteria, Biochemistry, Anti-Bacterial Agents, Adenosine Triphosphate, effector, Allosteric Regulation, cryo-EM single particle analysis, Humans, Amino Acid Sequence, Guanosine Triphosphate, enzyme regulation, Nucleoside-Phosphate Kinase, Uridine Monophosphate, Molecular Biology, UMP kinase
Abstract

International audience; Tuberculosis claims significantly more than one million lives each year. A feasible way to face the issue of drug resistance is the development of new antibiotics. Bacterial uridine 5’-monophosphate (UMP) kinase is a promis- ing target for novel antibiotic discovery as it is essential for bacterial sur- vival and has no counterpart in human cells. The UMP kinase from M. tuberculosis is also a model of particular interest for allosteric regula- tion with two effectors, GTP (positive) and UTP (negative). In this study, using X-ray crystallography and cryo-electron microscopy, we report for the first time a detailed description of the negative effector UTP-binding site of a typical Gram-positive behaving UMP kinase. Comparison between this snapshot of low affinity for Mg-ATP with our previous 3D-structure of the GTP-bound complex of high affinity for Mg-ATP led to a better understanding of the cooperative mechanism and the allosteric regulation of UMP kinase. Thermal shift assay and circular dichroism experiments corroborate our model of an inhibition by UTP linked to higher flexibility of the Mg-ATP-binding domain. These new structural insights provide valuable knowledge for future drug discovery strategies targeting bacterial UMP kinases.

Published
2022

3. Deciphering the Unexpected Binding Capacity of the Third PDZ Domain of Whirlin to Various Cochlear Hair Cell Partners

Author

Baptiste Colcombet-Cazenave, Ariel E. Mechaly, Sylviane Hoos, Nicolas Wolff, Florence Cordier, Célia Caillet-Saguy, Susanne Lüchow, Ahmed Haouz, Ylva Ivarsson, Bertrand Raynal, Amel Bahloul, Yanlei Zhu, Elise Pepermans, Florent Delhommel, Sébastien Brûlé, Candice Gautier, Virginie Girault, Récepteurs Canaux - Channel Receptors, Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Ecole Doctorale Complexité du Vivant (ED515), Sorbonne Université (SU), Bioinformatique structurale - Structural Bioinformatics, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Uppsala Universitet [Uppsala], Cristallographie (Plateforme) - Crystallography (Platform), Génétique et Physiologie de l'Audition, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Institut Pasteur, Fondation Cenci Bolognetti - Istituto Pasteur Italia, Fondazione Cenci Bolognetti, Réseau International des Instituts Pasteur (RIIP), Biophysique Moléculaire (plateforme) - Molecular Biophysics (platform), The project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement PDZnet No 675341. The authors also acknowledge the Conseil Régional d'Ile de France (France) for financial support through the SESAME 2014 NMRCHR program No. 14014526 (800 MHz spectrometer)., European Project: 675341,H2020-MSCA-ITN-2015,PDZNet(2016), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), and Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)

Subjects
Scaffold protein, Stereocilia (inner ear), [SDV]Life Sciences [q-bio], PDZ domain, PDZ Domains, Cell Cycle Proteins, Myosins, Stereocilia, 03 medical and health sciences, 0302 clinical medicine, Structural Biology, Myosin, Hair Cells, Auditory, medicine, otorhinolaryngologic diseases, Humans, Inner ear, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, CASK, Molecular Biology, Biology, 030304 developmental biology, 0303 health sciences, Stereocilium, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM], Chemistry, Membrane Proteins, Proteins, Cell biology, [SDV.BBM.BP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biophysics, Cytoskeletal Proteins, medicine.anatomical_structure, Hair cell, sense organs, Guanylate Kinases, 030217 neurology & neurosurgery, Protein Binding
Abstract

Hearing is a mechanical and neurochemical process, which occurs in the hair cells of inner ear that converts the sound vibrations into electrical signals transmitted to the brain. The multi-PDZ scaffolding protein whirlin plays a critical role in the formation and function of stereocilia exposed at the surface of hair cells. In this article, we reported seven stereociliary proteins that encode PDZ binding motifs (PBM) and interact with whirlin PDZ3, where four of them are first reported. We solved the atomic resolution structures of complexes between whirlin PDZ3 and the PBMs of myosin 15a, CASK, harmonin a1 and taperin. Interestingly, the PBM of CASK and taperin are rare non-canonical PBM, which are not localized at the extreme C terminus. This large capacity to accommodate various partners could be related to the distinct functions of whirlin at different stages of the hair cell development. (C) 2020 Published by Elsevier Ltd.

Published
2020
Full Text
View/download PDF

4. Structural insights into the functional versatility of an FHA domain protein in mycobacterial signaling

Author

Bertrand Raynal, Brigitte Vulliez-Le Normand, Tristan Wagner, Nathalie Barilone, Sylviane Hoos, María-Natalia Lisa, V. Hindie, Pedro M. Alzari, Helen M. O'Hare, Gwenaëlle André-Leroux, Marco Bellinzoni, Microbiologie structurale - Structural Microbiology (Microb. Struc. (UMR_3528 / U-Pasteur_5)), Université Paris Diderot - Paris 7 (UPD7)-Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Mathématiques et Informatique Appliquées du Génome à l'Environnement [Jouy-En-Josas] (MaIAGE), Institut National de la Recherche Agronomique (INRA), Biophysique Moléculaire (Plate-forme), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Leicester Tuberculosis Research Group (LTBRG) and Leicester Institute of Structural and Chemical Biology (LISCB), Department of Respiratory Science & Department of Molecular and Cell Biology, University of Leicester, This work was partially supported by grants from the Institut Pasteur and the CNRS. MNL received postdoctoral fellowships from EMBO (European Molecular Biology Organization) and FRM (Fondation pour la Recherche Medicale, France), Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], and Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris]

Subjects
Models, Molecular, Carboxy-Lyases, [SDV]Life Sciences [q-bio], Protein domain, Allosteric regulation, Protein Serine-Threonine Kinases, Crystallography, X-Ray, Biochemistry, 03 medical and health sciences, chemistry.chemical_compound, Bacterial Proteins, Amino Acid Sequence, Phosphorylation, Protein kinase A, Molecular Biology, Central element, 030304 developmental biology, Antigens, Bacterial, 0303 health sciences, Binding Sites, Phosphomimetics, 030306 microbiology, Forkhead Transcription Factors, Mycobacterium tuberculosis, Cell Biology, Protein Structure, Tertiary, Cell biology, chemistry, Docking (molecular), Mutation, Signal transduction, Protein Binding, Signal Transduction
Abstract

Forkhead-associated (FHA) domains are modules that bind to phosphothreonine (pThr) residues in signaling cascades. The FHA-containing mycobacterial protein GarA is a central element of a phosphorylation-dependent signaling pathway that redirects metabolic flux in response to amino acid starvation or cell growth requirements. GarA acts as a phosphorylation-dependent ON/OFF molecular switch. In its nonphosphorylated ON state, the GarA FHA domain engages in phosphorylation-independent interactions with various metabolic enzymes that orchestrate nitrogen flow, such as 2-oxoglutarate decarboxylase (KGD). However, phosphorylation at the GarA N-terminal region by the protein kinase PknB or PknG triggers autoinhibition through the intramolecular association of the N-terminal domain with the FHA domain, thus blocking all downstream interactions. To investigate these different FHA binding modes, we solved the crystal structures of the mycobacterial upstream (phosphorylation-dependent) complex PknB-GarA and the downstream (phosphorylation-independent) complex GarA-KGD. Our results show that the phosphorylated activation loop of PknB serves as a docking site to recruit GarA through canonical FHA-pThr interactions. However, the same GarA FHA–binding pocket targets an allosteric site on nonphosphorylated KGD, where a key element of recognition is a phosphomimetic aspartate. Further enzymatic and mutagenesis studies revealed that GarA acted as a dynamic allosteric inhibitor of KGD by preventing crucial motions in KGD that are necessary for catalysis. Our results provide evidence for physiological phosphomimetics, supporting numerous mutagenesis studies using such approaches, and illustrate how evolution can shape a single FHA-binding pocket to specifically interact with multiple phosphorylated and nonphosphorylated protein partners.

Published
2019

5. A Residue Quartet in the Extracellular Domain of the Prolactin Receptor Selectively Controls Mitogen-activated Protein Kinase Signaling

Author

Sylviane Hoos, Chi Zhang, Gitte W. Haxholm, Patrick England, Birthe B. Kragelund, Isabelle Broutin, Florence Boutillon, Mads Nygaard, Marie Bernadet, Vincent Goffin, Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Université Paris Descartes - Paris 5 (UPD5), University of Copenhagen = Københavns Universitet (KU), Biophysique des macromolécules et leurs interactions, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Laboratoire de cristallographie et RMN biologiques (LCRB - UMR 8015), Université Paris Descartes - Paris 5 (UPD5)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), This work was supported by the Danish Cancer Society grants (to B. B. K.), Danish Research Councils for Health and Disease Grants 09-072179 and 12-125862 (to B. B. K.), the Novo Nordic Foundation (to B. B. K.), Ligue Contre le Cancer Grant RS11/75-26 (to I. B.), University Paris Descartes Grant 990 UMRS 845/2011/02 (to V. G. and I. B.), and the Agence Nationale de la Recherche Grant ANR-07-PCVI-0029 (to V. G.)., ANR-07-PCVI-0029,PROLACTUMOR,Processus physiopathologiques impliquant le récepteur de la prolactine : approches physico-chimiques dynamiques et structurales(2007), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), University of Copenhagen = Københavns Universitet (UCPH), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), broutin, isabelle, and Physique et chimie du vivant - Processus physiopathologiques impliquant le récepteur de la prolactine : approches physico-chimiques dynamiques et structurales - - PROLACTUMOR2007 - ANR-07-PCVI-0029 - PCVI - VALID

Subjects
MESH: Signal Transduction, MAPK/ERK pathway, Magnetic Resonance Spectroscopy, Nuclear Magnetic Resonance (NMR), [SDV]Life Sciences [q-bio], Ligands, STAT Transcription Factor, Biochemistry, MESH: Circular Dichroism, MESH: Protein Structure, Tertiary, 0302 clinical medicine, STAT5 Transcription Factor, MESH: Ligands, Extracellular Signal-Regulated MAP Kinases, Receptor, MESH: Extracellular Signal-Regulated MAP Kinases, MESH: Cytokines, 0303 health sciences, MESH: Protein Multimerization, Circular Dichroism, Cell Surface Receptor, Cell biology, [SDV] Life Sciences [q-bio], Extracellular Signal-regulated Kinase (ERK), 030220 oncology & carcinogenesis, Mitogen-activated protein kinase, Cytokines, Signal transduction, Cytokine receptor, MESH: Spectrometry, Fluorescence, Protein Binding, Signal Transduction, MAP Kinase Signaling System, Receptors, Prolactin, Biology, Cell Line, 03 medical and health sciences, MESH: Receptors, Prolactin, Cell surface receptor, MESH: Cell Proliferation, Extracellular, Humans, MESH: Protein Binding, Cytokine, Molecular Biology, Cell Proliferation, 030304 developmental biology, MESH: Humans, MESH: MAP Kinase Signaling System, MESH: Magnetic Resonance Spectroscopy, MESH: STAT5 Transcription Factor, Prolactin receptor, Cell Membrane, Cell Biology, Protein Structure, Tertiary, MESH: Cell Line, Spectrometry, Fluorescence, biology.protein, Protein Multimerization, MESH: Cell Membrane
Abstract

Cytokine receptors elicit several signaling pathways, but it is poorly understood how they select and discriminate between them. We have scrutinized the prolactin receptor as an archetype model of homodimeric cytokine receptors to address the role of the extracellular membrane proximal domain in signal transfer and pathway selection. Structure-guided manipulation of residues involved in the receptor dimerization interface identified one residue (position 170) that in cell-based assays profoundly altered pathway selectivity and species-specific bio-characteristics. Subsequent in vitro spectroscopic and nuclear magnetic resonance analyses revealed that this residue was part of a residue quartet responsible for specific local structural changes underlying these effects. This included alteration of a novel aromatic T-stack within the membrane proximal domain, which promoted selective signaling affecting primarily the MAPK (ERK1/2) pathway. Importantly, activation of the MAPK pathway correlated with in vitro stabilities of ternary ligand·receptor complexes, suggesting a threshold mean lifetime of the complex necessary to achieve maximal activation. No such dependence was observed for STAT5 signaling. Thus, this study establishes a residue quartet in the extracellular membrane proximal domain of homodimeric cytokine receptors as a key regulator of intracellular signaling discrimination. Background: Discrimination of cytokine receptor signaling pathways is poorly understood. Results: Manipulation of extracellular prolactin receptor interface residues selectively affected activation of the MAPK pathway but not the STAT5 pathway. Conclusion: MAPK pathway activation correlated with apparent ligand·receptor complex lifetimes suggesting pathway-specific lifetime thresholds for activation. Significance: Discrimination of prolactin receptor signaling is controlled by the extracellular homodimer receptor interface.

Published
2015

6. Characterization of the elongasome core PBP2 : MreC complex of Helicobacter pylori

Author

Sylviane Hoos, Christine Ebel, Alexandre Martins, Christine Schmitt, Frank Gabel, Chantal Ecobichon, Patrick England, Andréa Dessen, Pierre-Jean Matteï, Ivo G. Boneca, Meriem El Ghachi, Marie-Christine Prévost, and Frédéric Colland

Subjects
chemistry.chemical_classification, 0303 health sciences, 030306 microbiology, Cell, Periplasmic space, biochemical phenomena, metabolism, and nutrition, Biology, Cell morphology, Microbiology, Yeast, Bacterial cell structure, Amino acid, law.invention, 03 medical and health sciences, medicine.anatomical_structure, chemistry, Biochemistry, law, polycyclic compounds, Recombinant DNA, Biophysics, medicine, Surface plasmon resonance, Molecular Biology, 030304 developmental biology
Abstract

Summary The definition of bacterial cell shape is a complex process requiring the participation of multiple components of an intricate macromolecular machinery. We aimed at characterizing the determinants involved in cell shape of the helical bacterium Helicobacter pylori. Using a yeast two-hybrid screen with the key cell elongation protein PBP2 as bait, we identified an interaction between PBP2 and MreC. The minimal region of MreC required for this interaction ranges from amino acids 116 to 226. Using recombinant proteins, we showed by affinity and size exclusion chromatographies and surface plasmon resonance that PBP2 and MreC form a stable complex. In vivo, the two proteins display a similar spatial localization and their complex has an apparent 1:1 stoichiometry; these results were confirmed in vitro by analytical ultracentrifugation and chemical cross-linking. Small angle X-ray scattering analyses of the PBP2 : MreC complex suggest that MreC interacts directly with the C-terminal region of PBP2. Depletion of either PBP2 or MreC leads to transition into spherical cells that lose viability. Finally, the specific expression in trans of the minimal interacting domain of MreC with PBP2 in the periplasmic space leads to cell rounding, suggesting that the PBP2/MreC complex formation in vivo is essential for cell morphology.

Published
2011

7. Cadherin-23, myosin VIIa and harmonin, encoded by Usher syndrome type I genes, form a ternary complex and interact with membrane phospholipids

Author

Sylviane Hoos, Jean-Pierre Hardelin, Christine Petit, Vincent Michel, Patrick England, Anne Houdusse, Amel Bahloul, Sylvie Nouaille, Génétique et Physiologie de l'Audition, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut Curie [Paris], Institut Pasteur [Paris] (IP), Collège de France (CdF (institution)), This work was supported by LHW-Stiftung, Fondation Orange, Conny Maeva Foundation, ANR-05-MRAR-015-01, Raymonde and Guy Strittmatter Foundation (under the aegis of Fondation de France), FAUN Stiftung (Suchert Foundation). Funding to pay the Open Access Charge was provided by Unite de Genetique et Physiologie de l'Audition, Institut Pasteur, France., The authors thank Muriel Delepierre for NMR spectra, Raphaël Etournay and Alexandre Chenal for their advice in the preparation of LUV, Beatrice Amigues for myosin VIIa tail preparation, Bruno Baron for circular dichroism experiments, Jacqueline Levilliers for her help in the manuscript preparation and the staff of Dynamic Imaging platform of the Pasteur Institute., ANR-05-MRAR-0015,Usher type I,Physiopathologie du syndrome de Usher de type I : de la structure de la myosine VIIa et de l'harmonine à leur fonction dans les cellules ciliées auditives(2005), ENGLAND, Patrick, and Programme pluriannuel de recherche sur les maladies rares - Physiopathologie du syndrome de Usher de type I : de la structure de la myosine VIIa et de l'harmonine à leur fonction dans les cellules ciliées auditives - - Usher type I2005 - ANR-05-MRAR-0015 - MRAR - VALID

Subjects
Male, MESH: Cytoskeletal Proteins, [SDV]Life Sciences [q-bio], Cell Cycle Proteins, Plasma protein binding, MESH: Mice, Knockout, MESH: Cadherins, Mice, MESH: Protein Structure, Tertiary, Myosin, MESH: Hair Cells, Auditory, MESH: Animals, Ternary complex, Phospholipids, Genetics (clinical), Mice, Knockout, MESH: Protein Multimerization, Articles, General Medicine, Cadherins, [SDV] Life Sciences [q-bio], Biochemistry, Myosin VIIa, Female, Usher Syndromes, Protein Binding, Gene isoform, PDZ domain, MESH: Carrier Proteins, macromolecular substances, Myosins, Biology, Cell Line, MESH: Cell Cycle Proteins, Hair Cells, Auditory, otorhinolaryngologic diseases, Genetics, Molecular motor, Animals, Humans, MESH: Myosin VIIa, MESH: Protein Binding, MESH: Usher Syndromes, MESH: Mice, Molecular Biology, MESH: Phospholipids, MESH: Humans, Cadherin, MESH: Myosins, MESH: Male, Protein Structure, Tertiary, MESH: Cell Line, Cytoskeletal Proteins, Disease Models, Animal, Cytoplasm, Biophysics, sense organs, Protein Multimerization, MESH: Disease Models, Animal, Carrier Proteins, MESH: Female
Abstract

International audience; Cadherin-23 is a component of early transient lateral links of the auditory sensory cells' hair bundle, the mechanoreceptive structure to sound. This protein also makes up the upper part of the tip links that control gating of the mechanoelectrical transduction channels. We addressed the issue of the molecular complex that anchors these links to the hair bundle F-actin core. By using surface plasmon resonance assays, we show that the cytoplasmic regions of the two cadherin-23 isoforms that do or do not contain the exon68encoded peptide directly interact with harmonin, a submembrane PDZ (post-synaptic density, disc large, zonula occludens) domain-containing protein, with unusually high affinity. This interaction involves the harmonin Nter-PDZ1 supramodule, but not the C-terminal PDZ-binding motif of cadherin-23. We establish that cadherin-23 directly binds to the tail of myosin VIIa. Moreover, cadherin-23, harmonin and myosin VIIa can form a ternary complex, which suggests that myosin VIIa applies tension forces on hair bundle links. We also show that the cadherin-23 cytoplasmic region, harmonin and myosin VIIa interact with phospholipids on synthetic liposomes. Harmonin and the cytoplasmic region of cadherin-23, both independently and as a binary complex, can bind specifically to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2), which may account for the role of this phospholipid in the adaptation of mechanoelectrical transduction in the hair bundle. The distributions of cadherin-23, harmonin, myosin VIIa and PI(4,5)P 2 in the growing and mature auditory hair bundles as well as the abnormal locations of harmonin and myosin VIIa in cadherin-23 null mutant mice strongly support the functional relevance of these interactions.

Published
2010

8. Structural and functional insights into the malaria parasite moving junction complex

Author

Maryse Lebrun, Magali Roques, Graham A. Bentley, Sylviane Hoos, Martin J. Boulanger, Susann Langer, Bart W. Faber, Mauld H. Lamarque, Brigitte Vulliez-Le Normand, Frederick Saul, Michelle L. Tonkin, Immunologie structurale, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Department of Biochemistry and Microbiology, University of Victoria [Canada] (UVIC), Dynamique des interactions membranaires normales et pathologiques (DIMNP), Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Biophysique des Macromolécules et de leurs Interactions, Department of Parasitology, Biomedical Primate Research Centre [Rijswijk] (BPRC), This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP82915 to MJB and ANR-2009 MIEN-0222 grant to ML and GAB. MJB is a CIHR New Investigator and a Michael Smith Foundation for Health Research Scholar. MLT is supported by the Alexander Graham Bell Natural Sciences and Engineering Research Council Scholarship. MHL is supported by an ANR-2009 grant. FVO 25-545 protein and the different strains of PfAMA1 domains I and II were produced with funding of the European (Malaria) Vaccine Initiative., and Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)

Subjects
Models, Molecular, MESH: Protein Structure, Quaternary, [SDV]Life Sciences [q-bio], Protozoan Proteins, MESH: Amino Acid Sequence, Biochemistry, Protein structure, Molecular Cell Biology, MESH: Animals, Peptide sequence, lcsh:QH301-705.5, MESH: Protozoan Proteins, MESH: Plasmodium falciparum, MESH: Crystallization, Host cell membrane, 0303 health sciences, biology, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM], Transmembrane protein, 3. Good health, Cell biology, MESH: Surface Plasmon Resonance, Rhoptry neck, MESH: Membrane Proteins, Crystallization, MESH: Models, Molecular, Protein Binding, Research Article, lcsh:Immunologic diseases. Allergy, Protein Structure, Immunology, Molecular Sequence Data, Plasmodium falciparum, Antigens, Protozoan, MESH: Host-Parasite Interactions, Microbiology, Host-Parasite Interactions, 03 medical and health sciences, Virology, MESH: Polymorphism, Genetic, parasitic diseases, Genetics, MESH: Protein Binding, Animals, [SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology, Amino Acid Sequence, Apical membrane antigen 1, Protein Structure, Quaternary, Protein Interactions, Molecular Biology, Biology, 030304 developmental biology, MESH: Molecular Sequence Data, Polymorphism, Genetic, 030306 microbiology, Intracellular parasite, Cell Membrane, Membrane Proteins, Proteins, Surface Plasmon Resonance, biology.organism_classification, lcsh:Biology (General), Parasitology, lcsh:RC581-607, MESH: Antigens, Protozoan, MESH: Cell Membrane
Abstract

Members of the phylum Apicomplexa, which include the malaria parasite Plasmodium, share many features in their invasion mechanism in spite of their diverse host cell specificities and life cycle characteristics. The formation of a moving junction (MJ) between the membranes of the invading apicomplexan parasite and the host cell is common to these intracellular pathogens. The MJ contains two key parasite components: the surface protein Apical Membrane Antigen 1 (AMA1) and its receptor, the Rhoptry Neck Protein (RON) complex, which is targeted to the host cell membrane during invasion. In particular, RON2, a transmembrane component of the RON complex, interacts directly with AMA1. Here, we report the crystal structure of AMA1 from Plasmodium falciparum in complex with a peptide derived from the extracellular region of PfRON2, highlighting clear specificities of the P. falciparum RON2-AMA1 interaction. The receptor-binding site of PfAMA1 comprises the hydrophobic groove and a region that becomes exposed by displacement of the flexible Domain II loop. Mutations of key contact residues of PfRON2 and PfAMA1 abrogate binding between the recombinant proteins. Although PfRON2 contacts some polymorphic residues, binding studies with PfAMA1 from different strains show that these have little effect on affinity. Moreover, we demonstrate that the PfRON2 peptide inhibits erythrocyte invasion by P. falciparum merozoites and that this strong inhibitory potency is not affected by AMA1 polymorphisms. In parallel, we have determined the crystal structure of PfAMA1 in complex with the invasion-inhibitory peptide R1 derived by phage display, revealing an unexpected structural mimicry of the PfRON2 peptide. These results identify the key residues governing the interactions between AMA1 and RON2 in P. falciparum and suggest novel approaches to antimalarial therapeutics., Author Summary Malaria arises from infection of erythrocytes by single-cell parasites belonging to the genus Plasmodium, the species P. falciparum causing the most severe forms of the disease. The formation of a moving junction (MJ) between the membranes of the parasite and its host cell is essential for invasion. Two important components of the MJ are Apical Membrane Antigen 1 (AMA1) on the parasite surface and the Plasmodium rhoptry neck (RON) protein complex that is translocated to the erythrocyte membrane during invasion. The extra-cellular region of RON2, a component of this complex, interacts with AMA1, providing a bridge between the parasite and its host cell that is crucial for successful invasion. The parasite thus provides its own receptor for AMA1 and accordingly this critical interaction is not subject to evasive adaptations by the host. We present atomic details of the interaction of PfAMA1 with the carboxy-terminal region of RON2 and shed light on structural adaptations by each apicomplexan parasite to maintain an interaction so crucial for invasion. The structure of the RON2 ligand bound to AMA1 thus provides an ideal basis for drug design as such molecules may be refractory to the development of drug resistance in P. falciparum.

Published
2011

9. Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligands

Author

Camille Locht, René Wintjens, Patrick England, Guy Lippens, Xavier Carette, Sameh H. Soror, Nathalie Lecat-Guillet, Frédéric Frénois, Bertrand Dirié, Alain R. Baulard, Vincent Villeret, Alexandre Wohlkonig, Benoit Deprez, Eve Willery, Zoé Lens, Nicolas Blondiaux, Nicolas Willand, Sylviane Hoos, Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche Interdisciplinaire [Villeneuve d'Ascq] (IRI), Université de Lille, Sciences et Technologies-Université de Lille, Droit et Santé-Centre National de la Recherche Scientifique (CNRS), Vlaams Instituut voor Biotechnologie [Ghent, Belgique] (VIB), Université libre de Bruxelles (ULB), Université Lille Nord (France), Biostructures et Decouverte de Medicament, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé, Institut Pasteur [Paris] (IP), Unité de Glycobiologie Structurale et Fonctionnelle UMR 8576 (UGSF), Université de Lille-Centre National de la Recherche Scientifique (CNRS), We are indebted to the ESRF (Group BAG MX-485). Diffraction data for BDM31343 and EthR-BDM33066 were collected at the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) and at the ESRF (Group BAG MX-485), respectively.We are grateful to the machine and beamline scientists whose outstanding efforts have made these experiments possible., and ENGLAND, Patrick

Subjects
Models, Molecular, Protein Folding, In silico, MESH: Protein Folding, [SDV]Life Sciences [q-bio], Biologie structurale, Repressor, Biology, Crystallography, X-Ray, Ligands, chemistry.chemical_compound, Transcription (biology), MESH: Nuclear Magnetic Resonance, Biomolecular, Genetics, MESH: Ligands, TetR, Binding site, Nuclear Magnetic Resonance, Biomolecular, Molecular Biology, MESH: Mutagenesis, Molecular switch, Binding Sites, MESH: DNA, DNA, MESH: Crystallography, X-Ray, MESH: Amino Acid Substitution, Repressor Proteins, [SDV] Life Sciences [q-bio], Amino Acid Substitution, Biochemistry, chemistry, MESH: Binding Sites, Mutagenesis, MESH: Repressor Proteins, Biophysics, Protein folding, Biologie, MESH: Models, Molecular
Abstract

Ethionamide is an antituberculous drug for the treatment of multidrug-resistant Mycobacterium tuberculosis. This antibiotic requires activation by the monooxygenase EthA to exert its activity. Production of EthA is controlled by the transcriptional repressor EthR, a member of the TetR family. The sensitivity of M. tuberculosis to ethionamide can be artificially enhanced using synthetic ligands of EthR that allosterically inactivate its DNA-binding activity. Comparison of several structures of EthR co-crystallized with various ligands suggested that the structural reorganization of EthR resulting in its inactivation is controlled by a limited portion of the ligand-binding-pocket. In silico simulation predicted that mutation G106W may mimic ligands. X-ray crystallography of variant G106W indeed revealed a protein structurally similar to ligand-bound EthR. Surface plasmon resonance experiments established that this variant is unable to bind DNA, while thermal shift studies demonstrated that mutation G106W stabilizes EthR as strongly as ligands. Proton NMR of the methyl regions showed a lesser contribution of exchange broadening upon ligand binding, and the same quenched dynamics was observed in apo-variant G106W. Altogether, we here show that the area surrounding Gly106 constitutes the molecular switch involved in the conformational reorganization of EthR. These results also shed light on the mechanistic of ligand-induced allosterism controlling the DNA binding properties of TetR family repressors., JOURNAL ARTICLE, SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2011

10. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone

Author

Vincent Goffin, Johannes F. Van Agthoven, Chi Zhang, Isabelle Broutin, Bruno Baron, Bertrand Raynal, Patrick England, Estelle Tallet, Sylviane Hoos, Laboratoire de cristallographie et RMN biologiques (LCRB - UMR 8015), Université Paris Descartes - Paris 5 (UPD5)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Centre de recherche Croissance et signalisation (UMR_S 845), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), This work was supported, in part, by University Paris Descartes and the Agence Nationale de la Recherche (grant ANR-07-PCVI-0029). J.v.A., C.Z., and E.T. acknowledge the Ministère de l'Education Nationale de la Recherche et de la Technologie for fellowship support., ANR-07-PCVI-0029,PROLACTUMOR,Processus physiopathologiques impliquant le récepteur de la prolactine : approches physico-chimiques dynamiques et structurales(2007), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)

Subjects
Models, Molecular, MESH: Protein Structure, Quaternary, Receptors, Prolactin, [SDV]Life Sciences [q-bio], Protein Data Bank (RCSB PDB), MESH: Prolactin, Growth hormone receptor, Biology, Crystallography, X-Ray, 03 medical and health sciences, Paracrine signalling, MESH: Receptors, Prolactin, 0302 clinical medicine, Structural Biology, MESH: Protein Binding, Receptor, Autocrine signalling, Protein Structure, Quaternary, Molecular Biology, 030304 developmental biology, 0303 health sciences, MESH: Protein Multimerization, Prolactin receptor, Mutagenesis, Surface Plasmon Resonance, MESH: Crystallography, X-Ray, MESH: Amino Acid Substitution, MESH: Surface Plasmon Resonance, Cell biology, Prolactin, MESH: Mutagenesis, Site-Directed, Biochemistry, Amino Acid Substitution, 030220 oncology & carcinogenesis, Growth hormone receptor complex, Mutagenesis, Site-Directed, Protein Multimerization, MESH: Models, Molecular, Protein Binding
Abstract

International audience; The most promising approach to targeting the tumor-growth-promoting actions of prolactin (PRL) mediated by its autocrine/paracrine pathway has been the development of specific PRL receptor (PRLR) antagonists. However, the optimization of such antagonists requires a thorough understanding of the activation mechanism of PRLR. We have thus conducted a systematic X-ray crystallographic study in order to visualize the successive steps of PRLR activation by PRL. We report here the structure at 3.35 Å resolution of the 1:2 complex between natural PRL and two PRLR chains (PRLR1 and PRLR2), corresponding to the final activated state of PRLR. Further than our previously published structure involving an affinity-matured PRL variant, this structure allowed to visualize for the first time the loop L5 spanning PRLR2 residues Thr133-Phe140, revealing its central implication for the three intermolecular interfaces of the complex. We equally succeeded in obtaining a comprehensive picture of the PRLR-PRLR dimerization interface, also called stem-stem interface. Site-directed mutagenesis was conducted to probe the energetic importance of stem-stem contacts highlighted by the structure. Surprisingly, in spite of significant structural differences between the PRL/PRLR(2) complex and the 1:2 growth hormone/growth hormone receptor complex, our mutational data suggest that hot-spot residues that stabilize the receptor dimerization interface are equivalent in the two complexes. This study provides a new overall picture of the structural features of PRLR involved in stabilizing its complex with PRL.

Published
2010

11. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX

Author

Hanan Boujrad, Pascal Lenormand, Sylviane Hoos, Cédric Artus, Marie Noëlle Brunelle, Hans K. Lorenzo, Santos A. Susin, Patrick England, Ada Bouharrour, Abdelkader Namane, Jean Claude Rousselle, Victor J. Yuste, Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Universitat Autònoma de Barcelona (UAB), Protéomique (Plate-Forme), Institut Pasteur [Paris] (IP), Institut André Lwoff [Villejuif] ( IAL), Université Paris-Sud - Paris 11 - Faculté de médecine (UP11 UFR Médecine), Université Paris-Sud - Paris 11 (UP11), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), SAS is supported by INSERM, UPMC-Paris 6, CNRS, ANR (contract ANR-09-BLAN-0247-01), ARC (contracts 4043, 5104, and 7987), and Fondation de France., We thank A Nussenzweig (NIH, NCI, Bethesda) for immortalized H2AX-wt and H2AX−/− MEFs, NV Tomilin (Institute of Cytology, St Petersburg) for the H2AX and H2AXS139A cDNA, and M Segade and S Krantic for critical comments, ANR-09-BLAN-0247,AIFCICD(2009), ENGLAND, Patrick, and Blanc - - AIFCICD2009 - ANR-09-BLAN-0247 - Blanc - VALID

Subjects
Models, Molecular, MESH: Calpain, [SDV]Life Sciences [q-bio], Poly (ADP-Ribose) Polymerase-1, Cypa, MESH: Poly (ADP-Ribose) Polymerase-1, MESH: Down-Regulation, Histones, Mice, H2AX, MESH: Animals, Caspase, bcl-2-Associated X Protein, MESH: Histones, biology, Calpain, General Neuroscience, MESH: Cyclophilin A, Apoptosis Inducing Factor, Chromatin, Cell biology, [SDV] Life Sciences [q-bio], Histone, Caspases, Apoptosis-inducing factor, biological phenomena, cell phenomena, and immunity, Poly(ADP-ribose) Polymerases, programmed necrosis, Cyclophilin A, MESH: Models, Molecular, Programmed cell death, Methylnitronitrosoguanidine, Poly ADP ribose polymerase, Down-Regulation, PARP-1, General Biochemistry, Genetics and Molecular Biology, chromatin & transcription, Article, MESH: Chromatin, Cell Line, Necrosis, Bcl-2-associated X protein, Animals, MESH: bcl-2-Associated X Protein, cardiovascular diseases, Molecular Biology, MESH: Mice, MESH: Necrosis, MESH: DNA Damage, MESH: Caspases, General Immunology and Microbiology, MESH: Poly(ADP-ribose) Polymerases, MESH: Methylnitronitrosoguanidine, Fibroblasts, biology.organism_classification, MESH: Cell Line, MESH: Apoptosis Inducing Factor, MESH: Gene Deletion, MESH: Fibroblasts, differentiation & death AIF, biology.protein, Gene Deletion, DNA Damage
Abstract

International audience; Programmed necrosis induced by DNA alkylating agents, such as MNNG, is a caspase-independent mode of cell death mediated by apoptosis-inducing factor (AIF). After poly(ADP-ribose) polymerase 1, calpain, and Bax activation, AIF moves from the mitochondria to the nucleus where it induces chromatinolysis and cell death. The mechanisms underlying the nuclear action of AIF are, however, largely unknown. We show here that, through its C-terminal proline-rich binding domain (PBD, residues 543-559), AIF associates in the nucleus with histone H2AX. This interaction regulates chromatinolysis and programmed necrosis by generating an active DNA-degrading complex with cyclophilin A (CypA). Deletion or directed mutagenesis in the AIF C-terminal PBD abolishes AIF/H2AX interaction and AIF-mediated chromatinolysis. H2AX genetic ablation or CypA downregulation confers resistance to programmed necrosis. AIF fails to induce chromatinolysis in H2AX or CypA-deficient nuclei. We also establish that H2AX is phosphorylated at Ser139 after MNNG treatment and that this phosphorylation is critical for caspase-independent programmed necrosis. Overall, our data shed new light in the mechanisms regulating programmed necrosis, elucidate a key nuclear partner of AIF, and uncover an AIF apoptogenic motif.

Published
2010

12. Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2

Author

Vincent Goffin, Isabelle Broutin, Estelle Tallet, Paul A. Kelly, Patrick England, Johannes F. Van Agthoven, Sylviane Hoos, Jean-Baptiste Jomain, Birthe B. Kragelund, Bertrand Raynal, Arnaud Ducruix, Laboratoire de cristallographie et RMN biologiques (LCRB - UMR 8015), Université Paris Descartes - Paris 5 (UPD5)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Centre de recherche Croissance et signalisation (UMR_S 845), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), University of Copenhagen = Københavns Universitet (UCPH), This work was supported in part by INSERM, University Paris Descartes, and the Agence Nationale de la Recherche (Grant ANR-PCV07_183953)., Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), and University of Copenhagen = Københavns Universitet (KU)

Subjects
[SDV]Life Sciences [q-bio], MESH: Protein Structure, Secondary, Ligand Binding Protein, MESH: Amino Acid Sequence, MESH: Drug Design, Biochemistry, Protein Structure, Secondary, MESH: Recombinant Proteins, MESH: Protein Structure, Tertiary, 0302 clinical medicine, Protein structure, MESH: Structure-Activity Relationship, X-Ray Diffraction, MESH: Animals, Placental lactogen, Receptor, Peptide sequence, 0303 health sciences, Crystallography, MESH: Crystallography, MESH: X-Ray Diffraction, Ligand (biochemistry), Recombinant Proteins, MESH: Glycine, 3. Good health, MESH: Surface Plasmon Resonance, MESH: Mutagenesis, Site-Directed, Protein Structure and Folding, Dimerization, hormones, hormone substitutes, and hormone antagonists, MESH: Placental Lactogen, endocrine system, MESH: Rats, Stereochemistry, Receptors, Prolactin, Molecular Sequence Data, Glycine, MESH: Prolactin, MESH: Sheep, Biology, 03 medical and health sciences, Structure-Activity Relationship, MESH: Receptors, Prolactin, Structure–activity relationship, Animals, Humans, Amino Acid Sequence, Binding site, Molecular Biology, 030304 developmental biology, Binding Sites, Sheep, MESH: Humans, MESH: Molecular Sequence Data, Cell Biology, Surface Plasmon Resonance, Placental Lactogen, Prolactin, Protein Structure, Tertiary, Rats, MESH: Binding Sites, MESH: Dimerization, Drug Design, Mutagenesis, Site-Directed, 030217 neurology & neurosurgery
Abstract

International audience; We report the first crystal structure of a 1:2 hormone.receptor complex that involves prolactin (PRL) as the ligand, at 3.8-A resolution. Stable ternary complexes were obtained by generating affinity-matured PRL variants harboring an N-terminal tail from ovine placental lactogen, a closely related PRL receptor (PRLR) ligand. This structure allows one to draw up an exhaustive inventory of the residues involved at the PRL.PRLR site 2 interface, consistent with all previously reported site-directed mutagenesis data. We propose, with this description, an interaction model involving three structural components of PRL site 2 ("three-pin plug"): the conserved glycine 129 of helix alpha3, the hydrogen bond network involving surrounding residues (glycine cavity), and the N terminus. The model provides a molecular basis for the properties of the different PRL analogs designed to date, including PRLR antagonists. Finally, comparison of our 1:2 PRL.PRLR(2) structure with those of free PRL and its 1:1 complex indicates that the structure of PRL undergoes significant changes when binding the first, but not the second receptor. This suggests that the second PRLR moiety adapts to the 1:1 complex rather than the opposite. In conclusion, this structure will be a useful guiding tool for further investigations of the molecular mechanisms involved in PRLR dimerization and activation, as well as for the optimization of PRLR antagonists, an emerging class of compounds with high therapeutic potential against breast and prostate cancer.

Published
2010

13. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein

Author

Muriel Delepierre, Gene S. Tan, Françoise Mégret, Christophe Prehaud, Pauline Ménager, Matthias J. Schnell, Nicolas Wolff, Damien Chopy, Mireille Lafage, Elouan Terrien, Florence Cordier, Elodie Maitrepierre, Nicolas Babault, Monique Lafon, Patrick England, Sylviane Hoos, Henri Buc, Neuro-Immunologie Virale, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Résonance Magnétique Nucléaire des Biomolécules, Department of Microbiology and Immunology, Thomas Jefferson University-Jefferson Vaccine Centre, Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris] (IP), This work was supported by grants from Institut Pasteur (IP) and Agence Nationale pour la Recherche (ANR) MIME. E.T., D.C., and N.B. are recipients of Ministère de l’Education et de la Recherche fellowships, and P.M. is a recipient of an ANR fellowship., We thank P. Roux, J. D’Alayer, V. Bondet, E. Frachon, J. Bellalou, and J.-F. Charles from IP core facilities for their help. We thank S. Loh and P. Nicotera for the gift of the SH-SY5Y cells, B. Dietzschold for fruitful discussions, E. Vinolo and B. Ruggiero for help in two-hybrid result interpretation, and F. Rey for his support., Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Jefferson (Philadelphia University + Thomas Jefferson University), and Institut Pasteur [Paris]

Subjects
Cytoplasm, [SDV]Life Sciences [q-bio], MESH: Neurons, PDZ Domains, Apoptosis, Protein tyrosine phosphatase, MESH: Virulence, medicine.disease_cause, Biochemistry, Mice, 0302 clinical medicine, Viral Envelope Proteins, MESH: PDZ Domains, MESH: Animals, chemistry.chemical_classification, Neurons, 0303 health sciences, Gene knockdown, Virulence, Kinase, Protein Tyrosine Phosphatase, Non-Receptor Type 4, MESH: Amino Acid Substitution, MESH: Rabies virus, [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM], [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Rabies, PDZ domain, Biology, Protein Serine-Threonine Kinases, MESH: Protein-Serine-Threonine Kinases, 03 medical and health sciences, MESH: Rabies, medicine, Animals, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Molecular Biology, MESH: Mice, 030304 developmental biology, MESH: Protein Tyrosine Phosphatase, Non-Receptor Type 4, MESH: Apoptosis, MESH: Cytoplasm, Rabies virus, Cell Biology, Molecular biology, chemistry, Amino Acid Substitution, MESH: Viral Envelope Proteins, sense organs, Glycoprotein, 030217 neurology & neurosurgery
Abstract

International audience; The capacity of a rabies virus to promote neuronal survival (a signature of virulence) or death (a marker of attenuation) depends on the cellular partners recruited by the PDZ-binding site (PDZ-BS) of its envelope glycoprotein (G). Neuronal survival requires the selective association of the PDZ-BS of G with the PDZ domains of two closely related serine-threonine kinases, MAST1 and MAST2. Here, we found that a single amino acid change in the PDZ-BS triggered the apoptotic death of infected neurons and enabled G to interact with additional PDZ partners, in particular the tyrosine phosphatase PTPN4. Knockdown of PTPN4 abrogated virus-mediated apoptosis. Thus, we propose that attenuation of rabies virus requires expansion of the set of host PDZ proteins with which G interacts, which interferes with the finely tuned homeostasis required for survival of the infected neuron.

Published
2010

14. Novel svVEGF isoforms from Macrovipera lebetina venom interact with neuropilins

Author

Zohra Aloui, Hafedh Mejdoub, Habib Kharmachi, Pierre Yves Haumont, Ammar Gasmi, Patrick England, Michael Klagsbrun, Elena Geretti, Sylviane Hoos, Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Vascular Biology Program, Department of Surgery and Pathology, Harvard Medical School [Boston] (HMS), Applied Biosystems, Unité de Service Commun pour la Recherche, Faculté des Sciences de Sfax, Université de Sfax - University of Sfax-Université de Sfax - University of Sfax, and Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)

Subjects
Vascular Endothelial Growth Factor A, Gene isoform, Neuropilins, MESH: Rats, Biophysics, MESH: Viperidae, Vascular permeability, Venom, MESH: Neuropilin-2, Viper Venoms, MESH: Neuropilin-1, Biochemistry, Capillary Permeability, Mice, 03 medical and health sciences, MESH: Mice, Inbred C57BL, Neuropilin 1, Viperidae, Animals, MESH: Animals, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Rats, Wistar, Receptor, Molecular Biology, MESH: Mice, 030304 developmental biology, 0303 health sciences, biology, MESH: Vascular Endothelial Growth Factor Receptor-2, MESH: Vascular Endothelial Growth Factor A, 030302 biochemistry & molecular biology, MESH: Capillary Permeability, Cell Biology, MESH: Rats, Wistar, biology.organism_classification, Vascular Endothelial Growth Factor Receptor-2, Neuropilin-1, Neuropilin-2, Rats, Mice, Inbred C57BL, Snake venom, MESH: Viper Venoms, Macrovipera lebetina
Abstract

International audience; Increased vascular permeability and vasodilation are responses usually elicited by snake envenomation. In this report, we isolated from Macroviperalebetina venom two protein groups designated IC1 (Increasing Capillary1) and IC2 based on their activities on capillary permeability. Mass spectrometry analysis showed that IC1 contained four major proteins of 23,650, 24,306, 24,589 and 24,718Da, whereas IC2 contained three major proteins of 25,101, 25,194 and 25,298Da. N-terminal amino-acid sequencing revealed that IC1 and IC2 belong to the snake venom VEGF (svVEGF) family. IC1 and IC2 had a marked specificity for VEGFR-2, with affinities in the nanomolar range. Interestingly, they also bind to NRP1 and NRP2, with affinities in the micromolar range. This is the first report demonstrating that M. lebetina encodes several distinct svVEGFs, endowed with a capacity to interact with neuropilins. IC1 and IC2 could be valuable tools to understand the molecular properties of angiogenic factors and their receptors.

Published
2009

15. Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a

Author

Muriel Delepierre, Armelle Phalipon, Brigitte Vulliez-Le Normand, Frederick Saul, François-Xavier Theillet, Andrej Weintraub, Sylviane Hoos, Graham A. Bentley, Franco Felici, Laurence A. Mulard, Résonance Magnétique Nucléaire des Biomolécules, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Immunologie structurale, Biophysique des Macromolécules et de leurs Interactions, Università degli Studi del Molise (Unimol), Division of Clinical Bacteriology [Stockholm], Karolinska University Hospital [Stockholm]-Department of Laboratory Medicine [Karolinska Institutet], Karolinska Institutet [Stockholm]-Karolinska Institutet [Stockholm], Chimie des biomolécules, Pathogénie Microbienne Moléculaire, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported by funds from the Institut Pasteur, Centre National de la Recherche Scientifique, and the Ministère National de la Recherche et de la Technologie., We thank the staff of the ESRF (Grenoble, France) for providing facilities for diffraction measurements and for assistance., We thank Dr. Patrick England for valuable help in the analysis of SPR and ITC data. We thank Dr. Frédéric Bélot and Catherine Guerreiro for their contribution to the synthesis of oligosaccharides., Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Università degli Studi del Molise = University of Molise (UNIMOL), and Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Phage display, MESH: Shigella flexneri, Protein Conformation, Protein Data Bank (RCSB PDB), Molecular Conformation, Peptide, medicine.disease_cause, Crystallography, X-Ray, 01 natural sciences, Shigella flexneri, Mice, Protein structure, MESH: Protein Conformation, Structural Biology, MESH: Nuclear Magnetic Resonance, Biomolecular, MESH: Animals, chemistry.chemical_classification, 0303 health sciences, MESH: Peptides, [CHIM.ORGA]Chemical Sciences/Organic chemistry, O Antigens, Molecular mimicry, Biochemistry, Carbohydrate Sequence, Thermodynamics, MESH: Molecular Mimicry, [SDV.IMM]Life Sciences [q-bio]/Immunology, carbohydrate–peptide mimicry, MESH: Thermodynamics, crystal structure, Molecular Sequence Data, Biology, 010402 general chemistry, Antibodies, shigellosis, 03 medical and health sciences, Antigen, medicine, Animals, Molecular Biology, Nuclear Magnetic Resonance, Biomolecular, MESH: Mice, 030304 developmental biology, MESH: O Antigens, MESH: Carbohydrate Sequence, MESH: Molecular Conformation, MESH: Molecular Sequence Data, MESH: Antibodies, Molecular Mimicry, solution NMR structure, biology.organism_classification, MESH: Crystallography, X-Ray, 0104 chemical sciences, chemistry, Docking (molecular), Peptides, antibody complex
Abstract

International audience; The use of carbohydrate-mimicking peptides to induce immune responses against surface polysaccharides of pathogenic bacteria offers a novel approach to vaccine development. Factors governing antigenic and immunogenic mimicry, however, are complex and poorly understood. We have addressed this question using the anti-lipopolysaccharide monoclonal antibody F22-4, which was raised against Shigella flexneri serotype 2a and shown to protect against homologous infection in a mouse model. In a previous crystallographic study, we described F22-4 in complex with two synthetic fragments of the O-antigen, the serotype-specific saccharide moiety of lipopolysaccharide. Here, we present a crystallographic and NMR study of the interaction of F22-4 with a dodecapeptide selected by phage display using the monoclonal antibody. Like the synthetic decasaccharide, the peptide binds to F22-4 with micromolar affinity. Although the peptide and decasaccharide use very similar regions of the antigen-binding site, indicating good antigenic mimicry, immunogenic mimicry by the peptide was not observed. The F22-4-antigen interaction is significantly more hydrophobic with the peptide than with oligosaccharides; nonetheless, all hydrogen bonds formed between the peptide and F22-4 have equivalents in the oligosaccharide complex. Two bridging water molecules are also in common, adding to partial structural mimicry. Whereas the bound peptide is entirely helical, its structure in solution, as shown by NMR, is helical in the central region only. Moreover, docking the NMR structure into the antigen-binding site shows that steric hindrance would occur, revealing poor complementarity between the major solution conformation and the antibody that could contribute to the absence of immunogenic mimicry.

Published
2009

16. A global benchmark study using affinity-based biosensors

Author

Aykut Üren, Stephen G. Brohawn, Eva Muñoz, Kenneth Miller, Mike Scott, Heather Hughes, Yasmina Noubia Abdiche, Rohn Lee Millican, Anne W Emerick, Jonathan Brooks, Michael B. Murphy, Charlene S. Lee, Carmelo Di Primo, Joshua Ballard, Quyhn Trinh, Giuseppe A. Papalia, Cynthia S. Hinck, Kevin Thompson, Peter Flynn, Joshua S. Klein, Martin A. Wear, Mark Toews, Richard N. Bohnsack, Mohammed Yousef, Daniel Malashock, Gaetano Barbato, Jill Raymond, Alison Joyce, Min Hsiang Yang, Julie Rothacker, Patrick England, Ashique Rafique, Jacinto López-Sagaseta, Scott L. Klakamp, Daulet Satpaev, Monica Dines, Danny Terwey, Islay Campbell, Joshua Thompson, Ben Busby, Tanmoy Ganguly, Gerardo Gutierrez-Sanchez, Sergei Shikov, Kevin Lindquist, Momchilo Vuyisich, Asya Grinberg, Krista Witte, Yun Hee Cho, Yue Ji Li, Hubert Mantz, Ewa Pol, Gonzalo Obal, Brian J. Pak, María J. Hernáiz, Peter Kainz, Erk Gedig, Mary M. Murphy, Tsafir Bravman, Janus Krarup, Gabrielle Zeder-Lutz, John Quinn, Thomas E. Ryan, Pietro Brandani, Dawn Kernaghan, Anca Clabbers, M. Brent Waddell, Agnes Puskas, Petr Skládal, Sanjay Nilapwar, Kara Herlihy, Gregor Anderluh, Federico Torta, Eric Hommema, Andrej Bavdek, Rejane Guimaraes, Anthony M. Giannetti, Eric Fang, Henrik Anderson, Anne Birgitte Bagge Hagel, Schuyler B Corry, Mark R. Witmer, Phillippe Neuner, Sébastien Wieckowski, Nico Dankbar, Alanna Pinkerton, Suparna Mundodo, Trevor D. Chapman, Sylvie Canepa, Satya P. Yadav, Rostislav Skrabana, Oleksandr Kalyuzhniy, Phini S Katsamba, Vidya Chandrasekaran, Eugene G. Chomey, Dana Reichmann, Katy McGirr, Dotzlaf Joe Edward, Mireille Baltzinger, Ite A. Laird-Offringa, Liann Wang, Erica Boni, Tiffany Tsang, Zaneta Nikolovska-Coleska, Andreas Schoenemann, Yuki Abe, Jamie Furneisen, Kenneth T. Lewis, Eileen M. Lafer, John Corbin, Satyen Gautam, Yuguo Feng, Olan Dolezal, Sylviane Hoos, James R. Horn, Bianca Beusink, Jinlin Peng, Otto Pritsch, Kristian H. Schlick, Ryan James Darling, Malgorzata Mikolajczyk, Quincy L. Carter, Jason T. Schuman, Yang Liu, Abdelkrim Khadir, Loïc Martin, Mark Alan Lewis, Ganeshram Krishnamoorthy, Andrew W. Drake, Jason Baardsnes, George Korza, Jesper Pass, Judie Berlier, Melicia Gainey, Nguyen Ly, James R. Partridge, Rosy Calvert, Roberta D'Agata, Rebecca L. Rich, Monica E. Ferreira, Phillip Page, Frank John Podlaski, Jay Duffner, Ruchira Das Gupta, Melanie Wong, Sergei Bibikov, Jiejin Li, Paola Torreri, Bruce A. Andrien, Peter Spies, Christina Boozer, David G. Myszka, University of Utah School of Medicine [Salt Lake City], KaloBios Pharmaceuticals [San Francisco], Schering–Plough Biopharma [Palo Alto], Nomadics [Oklahoma City], Biochemistry and Molecular Biophysics [Pasadena], California Institute of Technology (CALTECH), Department of Biochemistry and Molecular Biophysics, Columbia University [New York], Hartwell Center for Bioinformatics and Biotechnology [Memphis], St. Jude Children’s Research Hospital [Memphis], Universität Zürich [Zürich] = University of Zurich (UZH), Molecular Probes/Invitrogen [Eugene], Institut de génétique et biologie moléculaire et cellulaire (IGBMC), Université Louis Pasteur - Strasbourg I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), MerckKGaA, Merck & Co. Inc, Abbott Bioresearch Center [Worcester], Institut de biologie cellulaire et moléculaire [Strasbourg], Université de Strasbourg (UNISTRA), Reichert [Depew}, Momenta Pharmaceuticals [Cambridge], XOMA (U.S.), Department of Chemical and Biomolecular Engineering, National University of Singapore, National University of Singapore (NUS), Department of Biology [Ljubljiana], Biotechnical Faculty, University of Ljubljana, Department of Biological Chemistry (Weizmann Institute of Science), Weizmann Institute of Science [Rehovot, Israël], Molecular Biotechnology Core Laboratory [Cleveland], Cleveland Clinic Foundation, ThermoFisher Scientific [Rockford], Biacore/GE Healthcare [Uppsala], AstraZeneca [Hayward], Neurodegeneration Research Department [Harlow], GlaxoSmithKline [Harlow], MedImmune, Biacore/GE Healthcare [Piscataway], Department of Biochemistry [Milwaukee], Medical College of Wisconsin [Milwaukee] (MCW), Alexion Pharmaceuticals [Cheshire], Applied Biosystems [Foster City], diaDexus [South San Francisco], Eli Lilly and Company [Indianapolis], Center for Applied Medical Research [Plamplona] (CIMA), Universidad de Navarra [Pamplona] (UNAV), EMD Lexigen Research Center [Billerica], Department of Cell Biology and Neuroscience [Rome], Istituto Superiore di Sanita [Rome], Département de Biologie structurale et Chimie - Department of Structural Biology and Chemistry, Institut Pasteur [Paris], Department of Chemistry [Atlanta], Georgia State University, University System of Georgia (USG)-University System of Georgia (USG), Pfizer/Rinat Laboratories [South San Francisco], PDLBioPharma [Fremont], Department of Biochemistry [San Antonio], University of Texas Health Science Center at San Antonio [San Antonio], Akubio [Cambridge], ARN : régulations naturelle et artificielle, Université Bordeaux Segalen - Bordeaux 2-Institut Européen de Chimie et de Biologie-Institut National de la Santé et de la Recherche Médicale (INSERM), Wyeth Research [Cambridge], Department of Biochemistry and Molecular Biology [Odense], University of Southern Denmark (SDU), NovoNordisk [Gentofte], Södertörns University College [Huddinge], Department of Biochemistry [Philadelphia], Temple University [Philadelphia], Pennsylvania Commonwealth System of Higher Education (PCSHE)-Pennsylvania Commonwealth System of Higher Education (PCSHE), U.S. Food and Drug Administration (FDA), Department of Biochemical Engineering [London], University College of London [London] (UCL), Merck [Rome], Roche [Palo Alto], University of Twente [Netherlands], Agensys [Santa Monica], Novartis [Emeryville], Massachusetts Institute of Technology (MIT), Northern Illinois University, Institut Pasteur de Montevideo, Réseau International des Instituts Pasteur (RIIP), University of Manchester [Manchester], Department of Physiology [Baltimore], University of Maryland [Baltimore], Complex Carbohydrate Research Center [Athens, GA, USA], University of Georgia [USA], Adnexus Therapeutics [Waltham}, Physiologie de la reproduction et des comportements [Nouzilly] (PRC), Institut National de la Recherche Agronomique (INRA)-Institut Français du Cheval et de l'Equitation [Saumur]-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), ForteBio [Menlo Park], University of Michigan [Ann Arbor], University of Michigan System, Human Genome Sciences [Rockville], Department of Chemical Sciences [Catania], University of Catania [Italy], Montana State University (MSU), GKT School of Biomedical Sciences [London], Organic and Pharmaceutical Chemistry Department [Madrid], Universidad Complutense de Madrid = Complutense University of Madrid [Madrid] (UCM), Bio-Rad Haifa, Institute of Chemistry [Taipei], Academia Sinica, Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston (UTHealth), Fred Hutchinson Cancer Research Center [Seattle] (FHCRC), Division of Molecular Structure [London], National Institute of Medical Research (UK), Centre for Translational and Chemical Biology, Institute of Structural and Molecular Biology [Edinburgh], University of Edinburgh, Acceleron Pharma [Cambridge], Biotechnology Research Institute [Montreal], National Research Council of Canada (NRC), CSIRO Health Sciences and Nutrition [Parkville], Battelle Biomedical Research Center [Columbus], Attana AB [Stockholm], Corning [USA], School of Life Sciences, Institute for Chemistry and Bioanalytics [Muttenz], University of Applied Sciences Northwestern Switzerland (FHNW), Bio-Rad [Hercules], Monsanto [Chesterfield], Genzyme [Cambridge], Saarland University [Saarbrücken], Institute of Neuroimmunology of SAS [Bratislava], Bristol-Myers Squibb [Princeton], Array Biopharma [Boulder], Service d'Ingénierie Moléculaire pour la Santé (ex SIMOPRO) (SIMoS), Médicaments et Technologies pour la Santé (MTS), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Department of biochemistry, Masaryk University, Masaryk University [Brno] (MUNI), University of Connecticut Health Center [Farmington], University of Southern California, Los Angeles, GeminX Biotechnologies [Montreal], Hoffman–La Roche [Nutley], IRBM, Pomezia [Rome], Ludwig Institute for Cancer Research, Regeneron Pharmaceuticals [Tarrytown], University of Muenster, Department of Molecular Biology [Salzburg], University of Salzburg, XanTec Bioanalytics [Muenster], Biosciences Division [Los Alamos], Los Alamos National Laboratory (LANL), Lumera [Bothell], Arizona State University [Tempe] (ASU), Dyax [Cambridge], Lombardi Comprehensive Cancer Center, Georgetown University, Department of Biochemistry [Seattle], University of Washington [Seattle], ZymoGenetics, Bio-Rad Canada [Edmonton], Bio-Rad Canada [Toronto], St Jude Children's Research Hospital, University of Ljubljana, Istituto Superiore di Sanità (ISS), Institut Pasteur [Paris] (IP), University of Texas Health Science Center at San Antonio [San Antonio, Tx, USA], University of Twente, Institut National de la Recherche Agronomique (INRA)-Institut Français du Cheval et de l'Equitation [Saumur] (IFCE)-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), University of Southern California (USC), Georgetown University [Washington] (GU), Pasteur Tunis, Institut, Institut National de la Recherche Agronomique (INRA)-Institut Français du Cheval et de l'Equitation [Saumur]-Université de Tours-Centre National de la Recherche Scientifique (CNRS), University of Zürich [Zürich] (UZH), Weizmann Institute of Science, Medical College of Wisconsin [Milwaukee], Centre National de la Recherche Scientifique (CNRS)-Université de Tours-Institut Français du Cheval et de l'Equitation [Saumur]-Institut National de la Recherche Agronomique (INRA), Complutense University of Madrid (UCM), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), and Masaryk University

Subjects
Analyte, Biophysics, Optical biosensor, Antibodies, Catalytic, Biosensing Techniques, Ligands, 01 natural sciences, Biochemistry, Article, Biacore, Glutathione transferase, 03 medical and health sciences, Surface plasmon resonance, Molecular Biology, Kinetic rate constant, 030304 developmental biology, Glutathione Transferase, 0303 health sciences, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Chromatography, Binding Sites, Chemistry, 010401 analytical chemistry, A protein, Proteins, Cell Biology, 0104 chemical sciences, Benchmarking, Kinetics, Yield (chemistry), Benchmark (computing), IR-68798, Biosensor, EWI-16945, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience; To explore the variability in biosensor studies, 150 participants from 20 countries were given the same protein samples and asked to determine kinetic rate constants for the interaction. We chose a protein system that was amenable to analysis using different biosensor platforms as well as by users of different expertise levels. The two proteins (a 50-kDa Fab and a 60-kDa glutathione S-transferase [GST] antigen) form a relatively high-affinity complex, so participants needed to optimize several experimental parameters, including ligand immobilization and regeneration conditions as well as analyte concentrations and injection/dissociation times. Although most participants collected binding responses that could be fit to yield kinetic parameters, the quality of a few data sets could have been improved by optimizing the assay design. Once these outliers were removed, the average reported affinity across the remaining panel of participants was 620 pM with a standard deviation of 980 pM. These results demonstrate that when this biosensor assay was designed and executed appropriately, the reported rate constants were consistent, and independent of which protein was immobilized and which biosensor was used. (C) 2008 Elsevier Inc. All rights reserved.

Published
2009

17. The FHA-containing protein GarA acts as a phosphorylation-dependent molecular switch in mycobacterial signaling

Author

Andrea Villarino, Gwenaëlle André-Leroux, Sonia Martins, Annemarie Wehenkel, Sylviane Hoos, Patrick England, Pedro M. Alzari, Alzari, Pedro M, Institut Pasteur [Paris], Institut Pasteur [Paris] (IP), Biochimie Structurale, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Biophysique des macromolécules et de leurs interactions (Plate-forme), This work was supported by grants from the Institut Pasteur, the CNRS (France) and the European Union (NM4TB, Contract No. LSHP-CT-2005-018923)., The authors gratefully acknowledge the professional technical assistance of J. d'Alayer, F. Groh, I. Miras and V. Bondet. Finally we thank Dr. M. Bellinzoni for helpful advice and constructive criticism, and European Project: LSHP-CT

Subjects
Circular dichroism, Protein Conformation, [SDV]Life Sciences [q-bio], Biophysics, Regulator, Glutamic Acid, Signal transduction, Calorimetry, Biochemistry, Mycobacterium tuberculosis, 03 medical and health sciences, Bacterial Proteins, Structural Biology, Genetics, Phosphorylation, Molecular Biology, Polyacrylamide gel electrophoresis, 030304 developmental biology, 0303 health sciences, biology, Kinase, Chemistry, 030302 biochemistry & molecular biology, Forkhead Transcription Factors, Cell Biology, biology.organism_classification, Protein Structure, Tertiary, Physical chemistry, FHA domain, Glycogen, Bacteria
Abstract

Fork-head associated (FHA) domains are widely found in bacteria, but their cellular functions remain unclear. Here, we focus on Mycobacterium tuberculosis GarA, an FHA-containing protein conserved in actinomycetes that is phosphorylated by different Ser/Thr protein kinases. Using various physicochemical approaches, we show that phosphorylation significantly stabilizes GarA, and that its FHA domain interacts strongly with the phosphorylated N-terminal extension. Altogether, our results indicate that phosphorylation triggers an intra-molecular protein closure, blocking the phosphothreonine-binding site and switching off the regulatory properties of GarA. The model can explain the reported functions of this mycobacterial protein as regulator of glycogen degradation and glutamate metabolism.Structured summary:MINT-6804218: GarA (uniprotkb:P64897) and GarA (uniprotkb:P64897) bind (MI:0407) by isothermal titration calorimetry (MI:0065)

Published
2009

18. Structural and Thermodynamic Bases for the Design of Pure Prolactin Receptor Antagonists

Author

Estelle Tallet, Patrick England, Arnaud Ducruix, Johannes F. Van Agthoven, Sylviane Hoos, Birthe B. Kragelund, Vincent Goffin, Isabelle Broutin, Paul A. Kelly, Jean-Baptiste Jomain, Centre de recherche Croissance et signalisation (UMR_S 845), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de cristallographie et RMN biologiques (LCRB - UMR 8015), Université Paris Descartes - Paris 5 (UPD5)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), University of Copenhagen = Københavns Universitet (UCPH), This work was supported in part by INSERM, University Paris Descartes, the Comité de Paris de la Ligue Nationale Contre le Cancer Grant R05/75-15, and the Danish Natural Research Council Grant 21040604. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked 'advertisement' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact., Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), and University of Copenhagen = Københavns Universitet (KU)

Subjects
MESH: Mutation, MESH: Rats, [SDV]Life Sciences [q-bio], MESH: Prolactin, Context (language use), MESH: Amino Acid Sequence, MESH: Drug Design, MESH: Hot Temperature, Biochemistry, MESH: Circular Dichroism, 03 medical and health sciences, MESH: Protein Structure, Tertiary, MESH: Receptors, Prolactin, MESH: Protein Binding, MESH: Animals, Receptor, Molecular Biology, 030304 developmental biology, MESH: Structural Homology, Protein, 0303 health sciences, MESH: Molecular Sequence Data, MESH: Humans, MESH: Kinetics, Chemistry, Prolactin receptor, 030302 biochemistry & molecular biology, Wild type, Antagonist, Cell Biology, MESH: Crystallography, X-Ray, Affinities, Prolactin, MESH: Glycine, MESH: Cell Line, MESH: Protein Denaturation, MESH: Thermodynamics, Antagonism, MESH: Models, Molecular
Abstract

International audience; Competitive antagonists of the human prolactin (hPRL) receptor are a novel class of molecules of potential therapeutic interest in the context of cancer. We recently developed the pure antagonist Del1-9-G129R-hPRL by deleting the nine N-terminal residues of G129R-hPRL, a first generation partial antagonist. We determined the crystallographic structure of Del1-9-G129R-hPRL, which revealed no major change compared with wild type hPRL, indicating that its pure antagonistic properties are intrinsically due to the mutations. To decipher the molecular bases of pure antagonism, we compared the biological, physicochemical, and structural properties of numerous hPRL variants harboring N-terminal or Gly(129) mutations, alone or combined. The pure versus partial antagonistic properties of the multiple hPRL variants could not be correlated to differences in their affinities toward the hPRL receptor, especially at site 2 as determined by surface plasmon resonance. On the contrary, residual agonism of the hPRL variants was found to be inversely correlated to their thermodynamic stability, which was altered by all the Gly(129) mutations but not by those involving the N terminus. We therefore propose that residual agonism can be abolished either by further disrupting hormone site 2-receptor contacts by N-terminal deletion, as in Del1-9-G129R-hPRL, or by stabilizing hPRL and constraining its intrinsic flexibility, as in G129V-hPRL.

Published
2007

19. Structure-based optimization of a PDZ binding motif within a viral peptide stimulates neurite outgrowth

Author

Cynthia Lefebvre-Omar, Alain Chaffotte, Florent Delhommel, Christophe Prehaud, Elouan Terrien, Sandrine Vitry, Renaud Vincentelli, Clara Bernard, Zakir Khan, Kevin Ricquier, Delphine Bohl, Monique Lafon, Nicolas Wolff, Henri Buc, Juan Ramirez, Neuro-Immunologie Virale - Viral Neuro-immunology, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Résonance Magnétique Nucléaire des Biomolécules, Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Architecture et fonction des macromolécules biologiques (AFMB), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP), This work was supported by the following grants: ANR (Agence Nationale de la Recherche), BSV8- 0008-01 MAST-2-PTEN. AFM (Association Française contre les Myopathies) Characterization of pathological defects in motor neurons derived from patients Amyotrophic Lateral Sclerosis (ALS). Grand Prix de l’Académie des Sciences/Fondation Générale de Santé, and Incentive grant from Institut Carnot -Pasteur Maladies Infectieuses Unraveling the neuroprotective functions and optimization of new neuroprotective compound . The research leading to the results on IP SC has received funding from the programs Investissements d’Avenir ANR -10- IAIHU -06 and ANR -11- INBS -0011- NeurATRIS : Translational Research Infrastructure for Biotherapies in Neurosciences. ET and FD are recipients of PhD fellowships from the Ministère de l’ Enseignement Supérieur et de la Recherche. CL-O was supported by a PhD fellowship from Revive (ANR -10 -LABX -73). We thank Sylviane Hoos (Biophysics Core, Institut Pasteur) for ITC expertise and the team of the Technology Core of the Center for Translational Science (CRT), Institut Pasteur, for their help our with the Incucyte Technology., ANR-13-BSV8-0008,MAST-2-PTEN,Etude structurale et fonctionnelle du complexe MAST2/PTEN, impliqué dans le contrôle de la survie neuronale.(2013), ANR-11-INBS-0011,NeurATRIS,Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences(2011), ANR-10-LABX-0073,REVIVE,Stem Cells in Regenerative Biology and Medicine(2010), Binet, Caroline, Blanc 2013 - Etude structurale et fonctionnelle du complexe MAST2/PTEN, impliqué dans le contrôle de la survie neuronale. - - MAST-2-PTEN2013 - ANR-13-BSV8-0008 - Blanc 2013 - VALID, Infrastructures - Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences - - NeurATRIS2011 - ANR-11-INBS-0011 - INBS - VALID, Laboratoires d'excellence - Stem Cells in Regenerative Biology and Medicine - - REVIVE2010 - ANR-10-LABX-0073 - LABX - VALID, Neuro-Immunologie Virale, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [APHP]-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris], ANR: 11-INBS-0011,NeurATRIS,Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences(2011), ANR-10-LABX-0073/10-LABX-0073,REVIVE,Stem Cells in Regenerative Biology and Medicine(2010), Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), and Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)

Subjects
0301 basic medicine, viral protein, neurite outgrowth, Neurite, Viral protein, structure function analysis, Nuclear Magnetic Resonance, Induced Pluripotent Stem Cells, Neuronal Outgrowth, PDZ domain, PDZ Domains, Peptide, Serine threonine protein kinase, Protein Serine-Threonine Kinases, medicine.disease_cause, Microtubules, Biochemistry, Protein–protein interaction, protein-protein interaction, Structure-Activity Relationship, Viral Proteins, 03 medical and health sciences, [SCCO]Cognitive science, Neurites, medicine, Humans, Protein Interaction Domains and Motifs, neurodegenerative diseases, Molecular Biology, Neurons, chemistry.chemical_classification, 030102 biochemistry & molecular biology, Kinase, [SCCO.NEUR]Cognitive science/Neuroscience, [SCCO.NEUR] Cognitive science/Neuroscience, Cell Biology, [SCCO] Cognitive science, serine/threonine protein kinase, Cell biology, 030104 developmental biology, chemistry, Rabies virus, Cytoplasm, Central Nervous System Stimulants, Interfering peptide, Peptides, therapeutical drug candidate
Abstract

International audience; Protection of neuronal homeostasis is a major goal in the management of neurodegenerative diseases. Microtubule-associated Ser/Thre kinase 2 (MAST2), inhibits neurite outgrowth, and its inhibition therefore represents a potential therapeutic strategy. We previously reported that a viral protein (G-protein from rabies virus) capable of interfering with protein-protein interactions between the PDZ domain of MAST2 and the C-terminal moieties of its cellular partners counteracts MAST2-mediated suppression of neurite outgrowth. Here, we designed peptides derived from the native viral protein to increase the affinity of these peptides for the MAST2 PDZ domain. Our strategy involved modifying the length and flexibility of the non-interacting sequence linking the two subsites anchoring the peptide to the PDZ domain. Three peptides, Neurovita1 (NV1), NV2, and NV3, were selected, and we found that they all had increased affinities for the MAST2 PDZ domain, with Kd values decreasing from 1300 to 60 nM, while target selectivity was maintained. A parallel biological assay evaluating neurite extension and branching in cell cultures revealed that the NV peptides gradually improved neural activity, with the efficacies of these peptides for stimulating neurite outgrowth mirroring their affinities for MAST2-PDZ. We also show that NVs can be delivered into the cytoplasm of neurons as a gene or peptide. In summary, our findings indicate that virus-derived peptides targeted to MAST2-PDZ stimulate neurite outgrowth in several neuron types, opening up promising avenues for potentially using NVs in the management of neurodegenerative diseases.

Published
2019

20. Binding of the unorthodox transcription activator, Crl, to the components of the transcription machinery

Author

Véronique Robbe-Saule, Gouzel Karimova, Annie Kolb, Françoise Norel, Patrick England, Lars F. Westblade, Institut Pasteur [Paris] (IP), Biophysique des Macromolécules et de leurs Interactions, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Rockefeller University [New York], Biochimie des Interactions Macromoléculaires, Génétique Moléculaire, and We thank Samita Sally Goyal for performing the β-galactosidase assays and Christelle Talhouarne and Sylviane Hoos for monitoring the first SPR experiments. We thank Henri Buc for helpful suggestions.

Subjects
BACTH, Transcription, Genetic, [SDV]Life Sciences [q-bio], bacterial adenylate cyclase two-hybrid, response units, SPR, RU, Sigma Factor, Plasma protein binding, Biology, Biochemistry, chemistry.chemical_compound, Bacterial Proteins, Transcription (biology), Sigma factor, MESH: Catalase, RNA polymerase, MESH: Promoter Regions, Genetic, MESH: Protein Binding, Transcription, Chromatin, and Epigenetics, Mode of action, Promoter Regions, Genetic, MESH: Bacterial Proteins, Molecular Biology, Gene, Transcription factor, Regulation of gene expression, MESH: Transcription, Genetic, fungi, MESH: Sigma Factor, food and beverages, Salmonella enterica, MESH: Transcription Factors, Cell Biology, DNA-Directed RNA Polymerases, Surface Plasmon Resonance, Catalase, MESH: DNA-Directed RNA Polymerases, MESH: Surface Plasmon Resonance, Cell biology, ciated holoenzyme, chemistry, MESH: Salmonella enterica, Protein Binding, Transcription Factors
Abstract

International audience; The small regulatory protein Crl binds to sigmaS, the RNA polymerase stationary phase sigma factor. Crl facilitates the formation of the sigmaS-associated holoenzyme (EsigmaS) and thereby activates sigmaS-dependent genes. Using a real time surface plasmon resonance biosensor, we characterized in greater detail the specificity and mode of action of Crl. Crl specifically forms a 1:1 complex with sigmaS, which results in an increase of the association rate of sigmaS to core RNA polymerase without any effect on the dissociation rate of EsigmaS. Crl is also able to associate with preformed EsigmaS with a higher affinity than with sigmaS alone. Furthermore, even at saturating sigmaS concentrations, Crl significantly increases EsigmaS association with the katN promoter and the productive isomerization of the EsigmaS-katN complex, supporting a direct role of Crl in transcription initiation. Finally, we show that Crl does not bind to sigma70 itself but is able at high concentrations to form a weak and transient 1:1 complex with both core RNA polymerase and the sigma70-associated holoenzyme, leaving open the possibility that Crl might also exert a side regulatory role in the transcriptional activity of additional non-sigmaS holoenzymes.

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results